Biochemical abnormalities and excitotoxicity in Huntington's disease brain

Annals of Neurology

Volumn 45, Issue 1, 1999, Pages 25-32

  Tabrizi, S J ^a   Cleeter, M W J ^a   Xuereb, J ^c   Taanman, J W ^a   Cooper, J M ^a   Schapira, A H V ^a,b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACONITATE HYDRATASE; ADENOSINE TRIPHOSPHATE; CITRATE SYNTHASE; CYTOCHROME C OXIDASE; FREE RADICAL; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HUNTINGTIN; MITOCHONDRIAL ENZYME; MUTANT PROTEIN; NITRIC OXIDE; SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BRAIN CORTEX; CAUDATE NUCLEUS; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; HUNTINGTON CHOREA; NERVE CELL NECROSIS; NEUROTOXICITY; PRIORITY JOURNAL; PUTAMEN; RESPIRATORY CHAIN;

ACONITATE HYDRATASE; ADULT; AGED; AGED, 80 AND OVER; BRAIN CHEMISTRY; BRAIN DISEASES; ELECTRON TRANSPORT; ELECTRON TRANSPORT COMPLEX II; ELECTRON TRANSPORT COMPLEX III; ENZYME ACTIVATION; FEMALE; FIBROBLASTS; GLUTATHIONE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; MITOCHONDRIA; MULTIENZYME COMPLEXES; NERVE TISSUE PROTEINS; NEUROBLASTOMA; NEUROPROTECTIVE AGENTS; NEUROTOXINS; NITRIC OXIDE; NITROSO COMPOUNDS; NUCLEAR PROTEINS; OXIDOREDUCTASES; S-NITROSOGLUTATHIONE; SUCCINATE CYTOCHROME C OXIDOREDUCTASE; SUCCINATE DEHYDROGENASE; TRINUCLEOTIDE REPEATS; TUMOR CELLS, CULTURED;

EID: 0032900574     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E     Document Type: Article

References (37)

1. Li XJ, Li SH, Sharp AH, et al. A huntingtin-associated protein enriched in brain with implications for pathology. Nature 1995;378:398-402
2. Burke JR, Enghild JJ, Martin ME, et al. Huntingtin and DRPI.A proteins selectively interact with the enzyme GAPDH. Nat Med 1996;2:347-350
3. Brennan WA, Bird ED, Aprille JR. Regional mitochondrial respiratory activity in Huntington's disease brain. J Neurochem 1985;44:1948-1950
4. Mann VM, Cooper JM, Javoy-Agid F, et al. Mitochondrial function and parental sex effect in Huntington's disease. Lancet 1990;336:749 (Letter)
5. Gu M, Cooper JM, Gash M, et al. Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol 1996;39: 385-389
6. Browne SE, Bowling AC, MacGarvey U, et al. Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann Neurol 1997;41: 646-653
7. Beal MF, Brouillet E, Jenkins B, et al. Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J Neurochem 1993;61:1147-1150
8. Ludolph AC, Seelig M, Ludolph A, et al. 3-Nitropropionic acid decreases cellular energy levels and causes neuronal degeneration in cortical explants. Neurodegeneration 1992;1:155-161
9. 10. Ann Neurol 1997;41:160-165
10. Martin WRW, Clark C, Ammann W, et al. Cortical glucose metabolism in Huntington's disease. Neurology 1992;42:223-229
11. Schapira AHV. Mitochondrial function in Huntington's disease: Clues for pathogenesis; prospects for treatment. Ann Neurol 1997;41:141-142
12. Novelli A, Reilly JA, Lysko PG, Henneberry RC. Glutamate becomes neurotoxic via the n-methyl-d-aspartate receptor when intracellular energy levels are reduced. Brain Res 1988;451: 205-212
13. Meyer J. Comparison of carbon monoxide, nitric oxide and nitrate as inhibitors of the nitrogenase from Clostridium pasteurium. Arch Biochem Biophys 1981;210:246-256
14. Reddy D, Lancaster JR Jr, Cornforth DP. Nitrate inhibition of Clostridium botulinum-electron spin resonance detection of iron in nitric oxide complexes. Science 1083;221:769-770
15. Hausladen A, Fridovich I. Superoxide and peroxynitrite inactivates aconitases, but nitric xoide does not. J Biol Chem 1994; 269:29405-29408
16. Castro L, Rodriguez, M, Radi R. Aconitase is readily inactivated by peroxynitrite, but not by its precursor nitric oxide. J Biol Chem 1994;47:29409-29415
17. Patel M, Day BJ, Crapo JD, et al. Requirement for Superoxide in excitotoxic cell death. Neuron 1996;16:345-355
18. Bodnar AG, Cooper JM, Holt IJ, et al. Nuclear complementation restores mtDNA levels in cultured cells from a patient with mtDNA depletion. Am J Hum Genet 1993;53:663-669
19. Schapira AHV, Cooper JM, Dexter D, et al. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 1990; 54:823-827
20. Heinz F, Freimuller B. GAPDH - from human tissues. Methods Enzymol 1982;89:301-305
21. Gardner PR, Nguyen DM, White CW. Aconitase is a sensitive and critical target of oxygen poisoning in cultured mammalian cells and in rat lungs. Proc Natl Acad Sci USA 1994;91: 12248-12252
22. Lai JCK, Clark JB. Preparation and properties of mitochondria derived from synaptosomes. Biochem J 1976;154:423-432
23. Ragan CI, Wilson MT, Darley-Usmat VM, Lowe PN. Subfractionation of mitochondria, and isolation of the proteins of oxidative phosphorylation. In: Darley Usmar VM, Richwood D, Wilson MT, eds. Mitochondria: a practical approach. Oxford: IRI. Press, 1987:79-112
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin reagent. J Biol Chem 1951;193:265-275
25. Stahl WL, Swanson PD. Biochemical abnormalities in Huntington's chorea brains. Neurology 1974;24:813-819
26. Butterworth J, Yates CM, Reynolds GP. Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase, and α-glutamyl transpeptide in postmortem brain from Huntington's disease and agonal cases. J Neurol Sci 1985;67:161-171
27. Schapira AHV, Cooper JM, Dexter D, et al. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 1990; 54:823-827
28. Gu M, Gash MT, Gooper JM, et al. Mitochondrial respiratory chain function in multiple system atrophy. Mov Disord 1997; 12:418-422
29. Olanow CW. A radical hypothesis for neurodegeneration. Trends Neurosci 1993;16:439-444
30. Sian J, Dexter DT, Lees AJ, et al. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 1994;36:348-355
31. Reynolds IJ, Hastings TG. Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J Neurosci 1995;15:3318-3327
32. Gardner PR, Raineri I, Epstein LB, White CW. Superoxide radical and iron modulate aconitase activity in mammalian cells. J Biol Chem 1995;270:13399-13405
33. Cleeter MJW, Cooper JM, Darley-Usmar VM, et al. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 1994;345:50-54
34. Cleeter MJW, Cooper JM, Schapira AHV. Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement. J Neurochem 1992;58:786-789
35. Zhang Y, Marcillat O, Giulivi C, et al. The oxidative inactivation of mitochondrial electron transport chain components and ATP. J Biol Chem 1990;265:16330-16336
36. Hartley A, Cooper JM, Schapira AHV. Iron induced oxidative stress and mitochondrial dysfunction: relevance to Parkinson's disease. Brain Res 1993;627:349-353
37. Thomas PK, Cooper JM, King RHM, et al. Myopathy in vitamin E deficient rats: muscle fibre necrosis associated with disturbances of mitochondrial function. J Anat 1993;183:451-461